We applied 10 fold cross validation (10CV) on the train set in order to evaluate PAGE-Bs performance and its prognostic power using CoxPH, and to tune the CSFM
Disclosures: Jessica Frankeberger: Nothing to Disclose, Melissa Choz: Nothing to Disclose, Tatyana Kushner: Gilead: Grant/Research Support, Gilead: Advisor, GSK: Advisor, Eiger: Advisor, Nancy Reau: Gilead: Grant/Research Support, eiger: Grant/Research Support, abbott: Consultant, Arbutus: Consultant, Gilead: Consultant, VIR: Consultant, Salix: Consultant, Salix: Grant/Research Support, AbbVie: Grant/Research Support, Adriane Wynn: Nothing to Disclose, Natasha Martin: Nothing to Disclose 1744 ESTIMATING LOCAL TRANSMISSION DYNAMICS OF HEPATITIS A VIRUS INCREASED INCIDENCE AMONG MEN WHO HAVE SEX WITH MEN IN NEW YORK CITY AND CALIFORNIA, 2016-2019 Oluwatosin Jegede 1 Ravi Goyal 1 Christl Donnelly 2 Megan Hofmeister 3 Lauren Stockman 4 Olivia Arizmendi 4 HaeNa Waechter 5 Julia Latash 5 Natasha Martin 1 , 1 University of California San Diego, 2 University of Oxford, UK, 3 Centers for Disease Control and Prevention, USA, 4 California Department of Public Health, 5 New York City Department of Health and Mental Hygiene Background: Hepatitis A is a vaccine-preventable disease
Pancreatitis, or inflammation of the pancreas, is a painful and serious disease
The information presented here does not replace professional medical guidance, diagnosis, or treatment
